Images
Contact
The recycling properties of Aβ40 and Aβ42 within amyloid fibrils recently described by a group of researchers led by Natàlia Carulla at IRB Barcelona are the focus of the American Chemical Society (ACS). The society devotes its latest Weekly PressPac to latest Carulla’s findings on β-amyloid protein dynamics. A one-page article addressing the implications of Carulla’s study in diseases such as Alzheimer’s or type 2 diabetes highlights the relevance of the results.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
